As the score of MetS components increased, the participants exhibited a consistent rise in BMI, SBP, DBP, liver enzymes (ALT, AST, GGT), total cholesterol (TC), triglycerides (TG) and fasting plasma glucose (FPG), along with a steady decrease in HDL-C. The gene discussed is GPT; the disease is metabolic syndrome.